Trial Profile
The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Feb 2019 Planned End Date changed from 1 Jan 2019 to 1 Aug 2020.
- 07 Feb 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Apr 2020.
- 21 Mar 2018 Planned End Date changed from 1 Feb 2018 to 1 Jan 2019.